❌

Normal view

Received — 10 September 2026 ⏭

Antisense oligonucleotides against Il6ra ameliorate cancer cachexia in mice

✇Molecular Therapy
By: Yuanyuan Wang · Qingtao Sun · Wenqiang Zheng · Lijie Han · Qian Zhang · Adrian R. Krainer · Bo Li
19 August 2026 at 08:00
Cancer cachexia is a devastating metabolic syndrome for which there are no approved treatments. Li and colleagues developed an RNA-targeted therapy, which ameliorates cachectic symptoms, reduces inflammation, and extends survival in mouse cancer models. The study provides an approach for treating cancer cachexia and paves the road for clinical studies.

ConvMem: Convolutional Memory for Long-Context Reasoning

✇cs.AI, q-bio.NC updates on arXiv.org
By: Hongming Zhang · Zhaozhen Gu · Fengshuo Bai · Ming Hao · Qingyang Zhang · Yuanyuan Wang · Shiyang Tang · Yanna Wang · Bo Xu
10 September 2026 at 12:00
arXiv:2609.10441v1 Announce Type: new Abstract: While Large Language Models (LLMs) have demonstrated impressive capabilities, they often struggle with extremely long contexts due to fixed context limits. To address this, sequential approaches like MemAgent extend the effective context by reading text in segments and iteratively updating a fixed-size memory. However, this sequential paradigm suffers from high latency and requires costly reinforcement learning (RL) training, which can lead to overfitting on specific datasets. To overcome these limitations, we propose ConvMem, a training-free, highly parallelizable framework that reformulates long-context reasoning as a hierarchical convolution. Inspired by CNNs, ConvMem treats an LLM prompted with a specific query as a convolutional kernel. This kernel summarizes text segments hierarchically, shortening the reasoning path from a linear chain into a logarithmic tree. Specifically, ConvMem integrates \textit{Configurable Strides} and \textit{Skip Connections} to ensure robust evidence capture and propagation, while employing \textit{Multi-Kernel Convolution} to decompose complex queries into disentangled semantic channels. This design not only mitigates error accumulation but also enables massive parallelization across both text segments and reasoning threads. Experiments on RULER-HotpotQA and RULER-2WikiMultiHopQA demonstrate that ConvMem outperforms training-free baselines and avoids the risk of overfitting to parametric priors often observed in RL-trained models on out-of-distribution tasks.
Received — 26 March 2026 ⏭

Ran Score: a LLM-based Evaluation Score for Radiology Report Generation

✇cs.AI, q-bio.NC updates on arXiv.org
By: Ran Zhang · Yucong Lin · Zhaoli Su · Bowen Liu · Danni Ai · Tianyu Fu · Deqiang Xiao · Jingfan Fan · Yuanyuan Wang · Mingwei Gao · Yuwan Hu · Shuya Gao · Jingtao Li · Jian Yang · Hong Song · Hongliang Sun
25 March 2026 at 12:00
arXiv:2603.22935v1 Announce Type: new Abstract: Chest X-ray report generation and automated evaluation are limited by poor recognition of low-prevalence abnormalities and inadequate handling of clinically important language, including negation and ambiguity. We develop a clinician-guided framework combining human expertise and large language models for multi-label finding extraction from free-text chest X-ray reports and use it to define Ran Score, a finding-level metric for report evaluation. Using three non-overlapping MIMIC-CXR-EN cohorts from a public chest X-ray dataset and an independent ChestX-CN validation cohort, we optimize prompts, establish radiologist-derived reference labels and evaluate report generation models. The optimized framework improves the macro-averaged score from 0.753 to 0.956 on the MIMIC-CXR-EN development cohort, exceeds the CheXbert benchmark by 15.7 percentage points on directly comparable labels, and shows robust generalization on the ChestX-CN validation cohort. Here we show that clinician-guided prompt optimization improves agreement with a radiologist-derived reference standard and that Ran Score enables finding-level evaluation of report fidelity, particularly for low-prevalence abnormalities.
Received — 14 March 2026 ⏭

NFATC2::NUTM2 Fusion Defines a Novel Primary Pulmonary Epithelial Tumor With a Distinctive Immunophenotype

✇Pulmonary nodule
By: Lanlan Feng · Qiao Liu · Xiaoyan Liu · Shumei Wang · Junting Li · Yu Han · Xiaorong Mu · Yuanyuan Wang · Junfeng Jiang · Chun Wu · Xiujuan Han · Shaojun Zhu · Fuqin Zhang · Jing Tian · Zhuo Wang · Wei Zhang · Li Gong
13 March 2026 at 18:00

Am J Surg Pathol. 2026 Jun 1;50(6):695-704. doi: 10.1097/PAS.0000000000002533. Epub 2026 Mar 13.

ABSTRACT

With the application of molecular techniques in pathologic diagnosis, several novel primary pulmonary epithelial tumors have been continuously discovered and classified under the WHO classification of thoracic tumors. Recently, a pulmonary tumor with NFATC2 :: NUTM2B fusion was first documented, but the spectrum of NFATC2::NUTM2 fusion variants and their associated pathologic features remains incompletely characterized. Coincidentally, we also found and described 6 primary pulmonary tumors harboring recurrent NFATC2::NUTM2A/E fusions through integrated genomic analysis. These patients, including 4 females and 2 males, with a median age of 53 years, presented with incidentally detected peripheral lung nodules composed of monotonous epithelioid cells arranged in cords, nests, and trabeculae within a prominent desmoplastic stroma. All tumors exhibited a consistent immunophenotype: CK5/6+/GATA3+/calponin+/EMA+/DOG1 (perinuclear dot-like staining)/p63-. High-throughput chromosome conformation capture (Hi-C) analysis showed the structural variation of NFATC2::NUTM2E in all 6 cases, whereas RNA sequencing detected the fusion transcripts in 5 cases ( NFATC2::NUTM2A , n=2; NFATC2::NUTM2E , n=3). Ultrastructural examination of 1 case suggested epithelial differentiation. All patients remained disease-free after complete resection (median follow-up: 24 mo; range: 9 to 41 mo). These findings define a novel primary pulmonary tumor entity driven by NFATC2::NUTM2 fusions, and characterized by a distinctive immunophenotype, expanding the spectrum of NUTM2 -associated neoplasms. Our study underscores the utility of multiomics approaches for characterizing rare neoplasms and provides a diagnostic framework for this entity.

PMID:41821426 | DOI:10.1097/PAS.0000000000002533

NFATC2::NUTM2 Fusion Defines a Novel Primary Pulmonary Epithelial Tumor With a Distinctive Immunophenotype

✇Omics In Lung
By: Lanlan Feng · Qiao Liu · Xiaoyan Liu · Shumei Wang · Junting Li · Yu Han · Xiaorong Mu · Yuanyuan Wang · Junfeng Jiang · Chun Wu · Xiujuan Han · Shaojun Zhu · Fuqin Zhang · Jing Tian · Zhuo Wang · Wei Zhang · Li Gong
13 March 2026 at 18:00

Am J Surg Pathol. 2026 Mar 13. doi: 10.1097/PAS.0000000000002533. Online ahead of print.

ABSTRACT

With the application of molecular techniques in pathologic diagnosis, several novel primary pulmonary epithelial tumors have been continuously discovered and classified under the WHO classification of thoracic tumors. Recently, a pulmonary tumor with NFATC2::NUTM2B fusion was first documented, but the spectrum of NFATC2::NUTM2 fusion variants and their associated pathologic features remains incompletely characterized. Coincidentally, we also found and described 6 primary pulmonary tumors harboring recurrent NFATC2::NUTM2A/E fusions through integrated genomic analysis. These patients, including 4 females and 2 males, with a median age of 53 years, presented with incidentally detected peripheral lung nodules composed of monotonous epithelioid cells arranged in cords, nests, and trabeculae within a prominent desmoplastic stroma. All tumors exhibited a consistent immunophenotype: CK5/6+/GATA3+/calponin+/EMA+/DOG1 (perinuclear dot-like staining)/p63-. High-throughput chromosome conformation capture (Hi-C) analysis showed the structural variation of NFATC2::NUTM2E in all 6 cases, whereas RNA sequencing detected the fusion transcripts in 5 cases (NFATC2::NUTM2A, n=2; NFATC2::NUTM2E, n=3). Ultrastructural examination of 1 case suggested epithelial differentiation. All patients remained disease-free after complete resection (median follow-up: 24 mo; range: 9 to 41 mo). These findings define a novel primary pulmonary tumor entity driven by NFATC2::NUTM2 fusions, and characterized by a distinctive immunophenotype, expanding the spectrum of NUTM2-associated neoplasms. Our study underscores the utility of multiomics approaches for characterizing rare neoplasms and provides a diagnostic framework for this entity.

PMID:41821426 | DOI:10.1097/PAS.0000000000002533

There are no more articles
❌